Pharmaceuticals News

SOUTH SAN FRANCISCO, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the receipt of Fast Track designation from the U.S. Food and Drug...

SciSparc Invests C$2.7 million and holds approximately 44.6% of NeuroThera’s issued and outstanding common shares following the financing TEL AVIV, Israel, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ...

– Jeromy Brink, MD, Mayo Clinic–trained vascular surgeon in Phoenix, is the first surgeon in Arizona to implant Symvess, the first and only FDA-approved bioengineered human blood vessel – – Symvess...

MediBeacon® Transdermal GFR System Nominated for 2026 Prix Galien USA Best Medical Technology

First patients dosed in OVERTURE, a Phase 1b/2a study evaluating EYC-0305, a potential long-acting anti-VEGF therapy designed for six-month or longer dosing intervals via standard intravitreal...

Dr. Camisasca joins Entera with 30 years of global pharmaceutical research and clinical development experience including roles at Sumitomo Pharma, Takeda, and Novartis Appointment further strengthens...

ELLON, United Kingdom, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Scottish craft brewer BrewDog, by Tilray Brands, Inc., today unveiled its 2026 Advent Calendar, a 24-day countdown bringing together...

General Oncology nominated for 2026 Prix Galien USA Award for Best Startup, after preliminary Phase 1 results for GO-4 in BRCA-mutated pancreatic cancer.

As a global medical cannabis leader, Tilray Medical supports continued policy development that strengthens physician confidence, protects patient access and provides a clear, sustainable framework for...

Als weltweit führender Anbieter von medizinischem Cannabis unterstützt Tilray Medical eine Weiterentwicklung der Regulierung, die das Vertrauen der Ärzteschaft stärkt, den Zugang der Patienten schützt...